{
    "SPADE_N_14422": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14422",
            "Peptide Name": "Api Ib T1A3N7A8 (Apidaecin IB T1,A3,N7,A8 variant, Pro-rich, PrAMPs, synthetic AMPs, UCLL1)",
            "Source": "expression library screen, amino acid substitution, insects, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "TNARPVNAPQPRPPHPRL",
            "Sequence Length": 18,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 2018.29,
            "PI": 12.0,
            "Hydrophobicity": -1.44,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Huang W, Baliga C, VÃ¡zquez-Laslop N, Mankin AS.2024",
                    "Reference": "Nucleic Acids Res. 2024 Jul 2:gkae567. doi: 10.1093/nar/gkae567.PubMed",
                    "Title": "Sequence diversity of apidaecin-like peptides arresting the terminating ribosome."
                }
            ],
            "Frequent Amino Acids": "PRA",
            "Absent Amino Acids": "CDEFGIKMOSUWY",
            "Basic Residues": 4,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 10,
            "Polar Residues": 11,
            "Positive Residues": 4,
            "Negative Residues": 0,
            "Net Charge": 4,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (77.78%) toApidaecin IBP: 33%, R: 17%, A=N: 11%.Activity: it inhibited E. coli BL21 (MIC 8-64 uM) in RPMI/serum or TSB and MIC>64 uM in LB. Activity in LB < RPMI < TSB. It appears that this Pro-rich peptide is more active in the TSB medium. Warning: Other bacteria not tested.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_26297",
                    "Similarity": 1.0,
                    "Sequence": "TNARPVNAPQPRPPHPRL"
                },
                {
                    "SPADE_ID": "SPADE_N_09139",
                    "Similarity": 1.0,
                    "Sequence": "PQPRPPHPRL"
                },
                {
                    "SPADE_ID": "SPADE_UN_27444",
                    "Similarity": 1.0,
                    "Sequence": "PQPRPPHPRL"
                }
            ]
        }
    }
}